Skip to Main Content

++

DIAGNOSIS/INDICATION

++

History

++

  1. Seizure-predisposing conditions in the neonate are, for example,

    • Asphyxia

    • Prolonged low Apgar scores/resuscitation

    • Birth trauma

    • Sepsis or central nervous system (CNS) infection

  2. Maternal factors

    • Diabetes (hypoglycemic infant)

    • Fever/chorioamnionitis (sepsis)

    • Viral infection (eg, herpes)

    • Group B streptococcus carriage

  3. Pharmacologically restrained and sedated neonates with “at-risk” conditions

  4. Family history of siblings or parents with recognized or suspected genetic conditions predisposing to seizures (eg, benign familial neonatal seizure [BFNS], tuberous sclerosis)

++

Physical

++

  1. Dysmorphic features or multiple congenital anomalies (suggesting possible cerebral malformation)

  2. Seizures most commonly occur as repeated, stereotyped episodes of

    • Focal clonic limb jerking

    • Tonic limb posturing with or without head and eye deviation

    • Subtle phenomena, such as stereotyped chewing, tongue thrusting, bicycling, or swimming movements

    • Vital sign changes (eg, apnea, tachycardia, hypo- or hypertension)

++

Confirmatory/Baseline Tests

++

  1. Initial blood tests

    • Glucose

    • Electrolytes

    • Calcium/magnesium

    • Culture

    • Complete blood cell count and differential

  2. Urine analysis and culture

  3. Cerebrospinal fluid

    • Cell count and differential

    • Glucose (simultaneous serum glucose recommended) and protein

    • Bacterial and viral cultures

    • Herpes polymerase chain reaction (PCR)

  4. Electroencephalogram (EEG) to look for evidence of frequent or continuous seizures, correlate suspicious movements with ictal EEG rhythm, features suggesting focal cortical dysfunction or underlying inborn error of metabolism

  5. Neuroimaging

    • Ultrasound (intraparenchymal hemorrhage, malformation with ventriculomegaly)

    • Computerized tomography (intraparenchymal and superficial hemorrhage, cerebral malformation, intraparenchymal calcification [congenital infection])

    • Magnetic resonance imaging (MRI) (cerebral malformation, stroke, hemorrhage, sinovenous thrombosis, vascular malformation)

++

Further Tests

++

  1. Further blood tests

    • Amino acids

    • Arterial lactate, pyruvate, and ammonia levels

    • Carnitine level and acyl-carnitine profile

    • Karyotype

    • Hepatic enzymes

    • Biotinidase

  2. Urine

    • Organic acids

    • Purine and pyrimidine metabolites

    • Sulfites

  3. Many other possible diagnostic and screening tests for genetic conditions/inborn errors of metabolism depending on circumstances

++

Differential Diagnosis/Diagnostic Algorithm

++

  • Physical examination: Vigorous stimulation and repositioning are often useful means to try to interrupt suspicious, seizure-like behavior that is, in fact, nonepileptic (eg, benign sleep myoclonus, jitteriness).

  • EEG testing (as previously described) should help differentiate subtle seizures from nonepileptic behaviors (eg, apnea, tachycardia, oxygen desaturation).

  • Consider long-term EEG monitoring for less-frequent, stereotyped, seizure-like behavior.

++

TREATMENT/PROCEDURE

++

Initiation

++

  • Monitor respiratory and cardiac function, oral secretions.

  • Secure vascular access.

++

Tests to Follow

++

  • Correct deranged metabolic conditions: hypoxia, hypoglycemia, hypocalcemia, hypomagnesaemia, hyponatremia.

  • Once treatment with an antiseizure medication is initiated, follow serum levels of readily measurable drugs (eg, phenobarbital, phenytoin).

++

Management Algorithm/Decision Tree

++

  • Acute treatment with antiseizure medication: Initially consider a single dose of a benzodiazepine:

    • Lorazepam: 0.05 mg/kg/dose IV (preferred; longer duration of action)

    • Diazepam: 0.2 mg/kg/dose IV (hard to give, incompatible with most intravenous solutions, may precipitate or adhere to intravenous tubing)

    • Midazolam: 0.05 mg/kg/dose (very short duration of action)

  • Persistent clinical or electrograph seizures require longer-term treatment, classically with phenobarbital:

    • Load: 15–20 ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessPediatrics Full Site: One-Year Subscription

Connect to the full suite of AccessPediatrics content and resources including 20+ textbooks such as Rudolph’s Pediatrics and The Pediatric Practice series, high-quality procedural videos, images, and animations, interactive board review, an integrated pediatric drug database, and more.

$595 USD
Buy Now

Pay Per View: Timed Access to all of AccessPediatrics

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.